Automated Insulin Delivery Is Associated with Reduced Hospital Admissions and Costs for Acute Diabetes Complications in Children with Type 1 Diabetes
Authors' conclusion
AID use is associated with lower admission rates and ∼$40,000 savings per 100 patient-years compared with MDI.
Study context
- Population
- Western Australian children with T1D; admissions for DKA or hypoglycemia, January 5, 2022–April 30, 2024; admissions for newly diagnosed T1D excluded
- Participants
- 1,440 children2,674 patient-years
- Exposure
- Automated insulin delivery (AID) vs non-AID pump vs insulin injections
- Outcome
- Hospital admissions for DKA or hypoglycemia
Methodological detailspopulation-based, adjusted for age, diabetes duration and socioeconomic status
- Population-based
- Adjusted for age, diabetes duration and socioeconomic status
Main finding
As reported in the abstract
Admissions for DKA or hypoglycemia per 100 patient-years
Each group vs AIDAdjusted incidence rate ratio (95% CI)P value
MDI
2.74(1.39–5.42)
P = 0.0036Non-AID pump
1.62(0.84–3.14)
P = 0.150Observational data: associations, not effects.
Further findings
Hospital costs per 100 patient-years
- Hospital costs per 100 patient-years: valued using 2023-2024 Australian hospital data
Original publication
Automated Insulin Delivery Is Associated with Reduced Hospital Admissions and Costs for Acute Diabetes Complications in Children with Type 1 Diabetes. Diabetes Technol Ther. Published 13 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →